SCHEMBL30544705

SCHEMBL30544705

C[C@H]1CN(C)CCN1c1cc2cn[nH]c(=O)c2cn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 2/20 0.38
▸ LRRK2 Q5S007 1/20 0.38
▸ POLB P06746 1/20 0.35
▸ TRPC5 Q9UL62 1/20 0.34
▸ MTOR P42345 1/20 0.34
▸ FPR2 P25090 3/20 0.34
▸ CHRNA7 P36544 2/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ TRPV4 Q9HBA0 1/20 0.34
▸ CHEK1 O14757 1/20 0.34
▸ ATR Q13535 1/20 0.34
▸ PDCD1 Q15116 1/20 0.34
▸ ATRIP Q8WXE1 1/20 0.34
▸ CD274 Q9NZQ7 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.33
▸ PARP1 P09874 1/20 0.33
▸ PRKCI P41743 1/20 0.33
▸ PDE4B Q07343 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30544685 1.00 GSK3B (0.38) GSK3BLRRK2POLBTRPC5MTOR
SCHEMBL30544672 0.80 HTR3A (0.51) POLBPARP1TNKS
SCHEMBL30544688 0.73 PARP1 (0.34) POLBMTORALDH1A1PARP1PRKCI
SCHEMBL30544670 0.73 CHRNA7 (0.39) POLBCHRNA7KCNH2ALDH1A1PARP1
SCHEMBL30544681 0.71 MAP4K4 (0.41) KCNH2ATRATRIPPARP1
SCHEMBL30544664 0.71 MAP4K4 (0.41) KCNH2ATRATRIPPARP1
SCHEMBL30544699 0.71 MAP4K4 (0.41) KCNH2ATRATRIPPARP1
SCHEMBL30544663 0.71 ATM (0.42) LRRK2MTORATR
SCHEMBL30544673 0.70 POLB (0.38) GSK3BPOLBMTORALDH1A1PARP1
SCHEMBL30544668 0.70 TIPARP (0.41) PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116635371-A Polycyclic pyridazinone derivative serving as SOS1 inhibitor, and preparation method and application thereof 苏州阿尔脉生物科技有限公司 2023-08-22 — — CN disclosed
Send feedback